Link to this page
STO
Last uploaded:
November 28, 2017
Jump to:
Preferred Name | Dabigatran | |
Synonyms |
|
|
ID |
http://www.semanticweb.org/ontologies/STO.owl#OWLClass_ae82087a_9e10_4c3e_919c_50c61c028de4 |
|
hasDbXref | ||
isDefinedBy |
Dabigatran etexilate is the orally administered prodrug and is rapidly converted by tissue esterases to dabigatran, a direct thrombin inhibitor. When taken by mouth, the bioavailability of dabigatran is approximately 7%.
|
|
label |
Dabigatran
|
|
prefixIRI |
OWLClass_ae82087a_9e10_4c3e_919c_50c61c028de4
|
|
prefLabel |
Dabigatran
|
|
references |
Alberts, M. J., Bernstein, R. A., Naccarelli, G. V., & Garcia, D. A. (2012). Using Dabigatran in Patients With Stroke A Practical Guide for Clinicians. Stroke, 43(1), 271-279.
|
|
subClassOf |
http://www.semanticweb.org/ontologies/STO.owl#OWLClass_b1f6b40e_dbaa_44e7_a0c2_d45e96672923 |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping